Health insurance coverage in the United States has reached an all-time high under the Biden Administration, as per the latest data released by the U.S. Department of the Treasury.Nearly 50 million Americans, or 1 in 7 U.S. residents, have been covered through the Affordable Care Act marketplaces since January 2014.

根据美国财政部发布的最新数据，拜登政府时期美国的医疗保险覆盖率创历史新高。自2014年1月以来，近5000万美国人，即每7名美国居民中就有1名，已经通过《平价医疗法案》市场覆盖。

By lowering the cost of marketplace coverage by expanding the premium tax credit, the number of Americans covered through the marketplaces has significantly increased, reaching an all-time high of 20.8 million, following open enrollment for 2024. 18.2 million Americans have enrolled for the first time since January 2021, the data shows..

通过扩大保费税收抵免来降低市场覆盖成本，通过市场覆盖的美国人数量大幅增加，继2024年开放招生后，达到了2080万的历史新高。数据显示，自2021年1月以来，已有1820万美国人首次注册。。

In a statement responding to the Census Income, Poverty and Health Insurance Coverage reports, President Joe Biden said, 'Today's reports show we are making real progress growing the middle class, with incomes up more than $3,000 last year and up since Vice President Harris and I took office, accounting for inflation.

乔·拜登总统在一份针对人口普查收入、贫困和医疗保险覆盖率报告的声明中说，“今天的报告显示，我们正在中产阶级的发展中取得真正的进展，去年收入增加了3000美元以上，自哈里斯副总统和我就任以来收入也有所增加，这是通货膨胀的原因。”。

In addition, health insurance coverage reached record highs under our Administration thanks to our work to build on the Affordable Care Act and lower health care costs'.He slammed Congressional Republicans for repeatedly blocking policies to restore the expanded Child Tax Credit and pass the government's plan to build millions of homes and make rent more affordable.

此外，由于我们在《平价医疗法案》的基础上努力降低医疗保健成本，我们管理下的医疗保险覆盖率达到了历史新高。他抨击国会共和党人一再阻挠恢复扩大的儿童税收抵免政策，并通过政府建造数百万套住房和提高租金负担能力的计划。

For comments and feedback contact: editorial@rttnews.comPolitical News.

如需评论和反馈，请联系：editorial@rttnews.comPolitical新闻。

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股